|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00241 ALI HEALTH
Nominal 
3.800 +0.010 (+0.264%) | 2024/09 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/09 RMB(K¥) | 2022/09 RMB(K¥) | 2021/09 RMB(K¥) | 2020/09 RMB(K¥) | |
| Turnover | 14,273,724 | 10.171% | 12,956,000 | 11,500,569 | 9,357,715 | 7,162,031 |
| Cost of Sales | (10,739,959) | 6.470% | (10,087,332) | (9,199,913) | (7,486,940) | (5,301,715) |
| Gross Profit | 3,533,765 | 23.185% | 2,868,668 | 2,300,656 | 1,870,775 | 1,860,316 |
| 2024/09 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/09 RMB(K¥) | 2022/09 RMB(K¥) | 2021/09 RMB(K¥) | 2020/09 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (21,451) | 161.885% | (8,191) | 385 | (24,385) | (38,901) | |
| Profit / (Loss) before Taxation | 821,069 | 70.604% | 481,271 | 173,975 | (229,862) | 324,441 | |
| Taxation | (52,021) | 43.991% | (36,128) | (10,466) | (1,706) | (45,887) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (95) | -- | 748 | (1,315) | (203) | 4,877 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 768,953 | 72.453% | 445,891 | 162,194 | (231,771) | 283,431 | |
| 2024/09 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/09 RMB(K¥) | 2022/09 RMB(K¥) | 2021/09 RMB(K¥) | 2020/09 RMB(K¥) | |
| Net Finance Costs / (Income) | (227,543) | 12.725% | (201,856) | (143,141) | (85,721) | (61,001) |
| Depreciation & Amortisation | 26,415 | 4.718% | 25,225 | 35,897 | 23,059 | 17,534 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/09 - Interim | %Chg (Compare to Interim) | 2023/09 | 2022/09 | 2021/09 | 2020/09 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/09 - Interim | %Chg (Compare to Interim) | 2023/09 | 2022/09 | 2021/09 | 2020/09 | |
| EPS (cts) | 4.790 | 45.152% | 3.300 | 1.200 | -1.720 | 2.170 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.949 | -- | 1.189 | -- | 1.043 | 1.075 |
| Remarks: | Real time quote last updated: 19/11/2024 11:02 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 768,953 |
| %Change | 72.453% |
| EPS / (LPS) | RMB 0.048 |
| NBV Per Share (¥) | RMB 0.949 |